Pharmarise Holdings Corporation

2796

JP3802320006

Drug Retailers

Delayed Japan Exchange Other stock markets 11:30:00 05/07/2024 am IST			5-day change	1st Jan Change
635 ^JPY	-0.31%		-0.31%	-3.79%

07/06	Tranche Update on Pharmarise Holdings Corporation's Equity Buyback Plan announced on January 11, 2024.	CI
11/04	Pharmarise Holdings’ Attributable Profit Down 15% in Fiscal Nine Months on Higher Expenses Following M&A	MT

Tranche Update on Pharmarise Holdings Corporation's Equity Buyback Plan announced on January 11, 2024.

June 07, 2024 at 01:30 pm IST

From March 1, 2024 to May 31, 2024, the company has repurchased 0 shares, representing 0% for ¥0 million. With this, the company has completed the repurchase of 496,000 shares, representing 4.23% for ¥340.26 million under the buyback announced on January 11, 2024.

Latest news about Pharmarise Holdings Corporation

Tranche Update on Pharmarise Holdings Corporation's Equity Buyback Plan announced on January 11, 2024.	07/06	CI
Pharmarise Holdings’ Attributable Profit Down 15% in Fiscal Nine Months on Higher Expenses Following M&A	11/04	MT
Pharmarise Holdings Corporation Revises Consolidated Earnings Guidance for the Fiscal Year Ending May 31, 2024	10/04	CI
Tranche Update on Pharmarise Holdings Corporation's Equity Buyback Plan announced on January 11, 2024.	14/03	CI
Pharmarise Holdings Corporation announces an Equity Buyback for 1,416,800 shares, representing 12.07% for ¥1,032 million.	11/01	CI
Pharmarise's Fiscal H1 Attributable Profit Soars as Net Sales Rise	11/01	MT
Pharmarise Holdings Corporation authorizes a Buyback Plan.	11/01	CI
Pharmarise Holdings Corporation entered into stock transfer agreement to acquire GOOD AID Inc. from Kotoshino Co., Ltd. and Yuta Hattori.	11/01	CI
Pharmarise Holdings Corporation Provides Consolidated Earnings Guidance for the Fiscal Year Ending May 31, 2024	10/01	CI
Pharmarise Holdings Corporation Provides Dividend Guidance for the Fiscal Year Ending May 31, 2024	12/23/12	CI
Pharmarise Holdings Corporation Provides Consolidated Earnings Guidance for the Six Months and Full Year of Fiscal Year Ending May 31, 2024	12/23/12	CI
Pharmarise Holdings Corporation acquired Nine Dispensing Pharmacies in Tokyo, Niigata, and Fukushima.	10/23/10	CI
Pharmarise Holdings Corporation Provides Dividend Guidance for the Fiscal Year Ending May 31, 2024	11/23/11	CI
Pharmarise Holdings Corporation Announces Commemorative Dividend for the Fiscal Year Ending May 31, 2024	11/23/11	CI
Pharmarise Holdings Corporation Declares Dividend for the Fiscal Year Ending May 31, 2023, Payable on August 31, 2023	11/23/11	CI
Pharmarise Holdings Corporation Provides Consolidated Earnings Guidance for the Six Months and Full Year of Fiscal Year Ending May 31, 2024	11/23/11	CI
Pharmarise Logs 35% Drop in FY23 Nine-month Profit on Higher Utility Expenses, Lower Drugstore Sales	11/23/11	MT
Pharmarise Holdings Corporation Provides Consolidated Earnings Guidance for the Fiscal Year Ending May 31, 2023	10/23/10	CI
Pharmarise Holdings Corporation Provides Dividend Guidance for the Fiscal Year Ending May 31, 2023	10/23/10	CI
Pharmarise Holdings Corporation entered into basic agreement to acquire Two Dispensing Pharmacies in Mie Prefecture.	14/23/14	CI
Pharmarise Holdings Corporation Provides Consolidated Earnings Guidance for the Full Year of Fiscal Year Ending May 31, 2023	12/23/12	CI
Pharmarise Holdings Corporation Provides Dividend Guidance for the Fiscal Year Ending May 31, 2023	12/23/12	CI
Pharmarise's Fiscal Q1 Attributable Profit Soars 75%	14/22/14	MT
Pharmarise Holdings Corporation Provides Consolidated Earnings Guidance for the Six Months and Full Year of Fiscal Year Ending May 31, 2023	13/22/13	CI
Pharmarise Holdings Corporation Provides Dividend Guidance for the Fiscal Year Ending May 31, 2023	13/22/13	CI

Chart Pharmarise Holdings Corporation

Duration

Period

More charts

Company Profile

Pharmarise Holdings Corporation is a Japan-based holding company primarily engaged in the dispensing pharmacy businesses. Along with its subsidiaries and associated companies, the Company operates in five business segments. The Dispensing Pharmacy segment is engaged in the operation of dispensing pharmacies, which prescribe medicines to general patients based on prescriptions issued by medical institutions. The Merchandising segment consists of the cosmetics sales business, the convenience store management business and the drug store management business. The Medical Document Storage and Management segment is engaged in the storage and management of paper medical records and X-ray films. The Medical Mall Management segment is a business related to medical malls operated at JR Tower Office Plaza Sapporo in JR Sapporo Station. Others segment includes temporary staffing business and sales of stationery.

Sector

Drug Retailers

Calendar

10/10/2024 - Q1 2025 Earnings Release (Projected)

More about the company

	1st Jan change	Capi.
PHARMARISE HOLDINGS CORPORATION	-3.79%	44.44M
RAIA DROGASIL S.A.	-14.49%	7.85B
AIN HOLDINGS INC.	+20.14%	1.21B
NIHON CHOUZAI CO.,LTD.	+7.72%	281M
SALUS, LJUBLJANA, D. D.	+8.89%	223M
PETMED EXPRESS, INC.	-47.09%	79.61M
GREEN CROSS HEALTH LIMITED	-32.11%	65.01M
MEDICAL IKKOU GROUP CO.,LTD.	+32.57%	63.45M

Retail - Drugs without Grocery

Pharmarise Holdings Corporation

Equities

2796

JP3802320006

Drug Retailers

Tranche Update on Pharmarise Holdings Corporation's Equity Buyback Plan announced on January 11, 2024.

Latest news about Pharmarise Holdings Corporation

Chart Pharmarise Holdings Corporation

Company Profile

Income Statement Evolution

Quarterly earnings - Rate of surprise

Sector Retail - Drugs without Grocery